Free Trial

Envestnet Portfolio Solutions Inc. Buys 4,378 Shares of Docusign Inc. $DOCU

Docusign logo with Computer and Technology background

Envestnet Portfolio Solutions Inc. lifted its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 106.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,510 shares of the company's stock after acquiring an additional 4,378 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Docusign were worth $663,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCU. Banque Transatlantique SA bought a new position in shares of Docusign in the first quarter worth approximately $26,000. Hemington Wealth Management raised its position in shares of Docusign by 318.1% during the 1st quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares during the period. Golden State Wealth Management LLC lifted its stake in shares of Docusign by 519.4% during the 1st quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after buying an additional 322 shares in the last quarter. Summit Securities Group LLC bought a new position in Docusign in the 1st quarter worth $34,000. Finally, Rise Advisors LLC increased its stake in Docusign by 864.6% in the 1st quarter. Rise Advisors LLC now owns 463 shares of the company's stock worth $38,000 after buying an additional 415 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have commented on DOCU. Wells Fargo & Company raised their price target on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a report on Friday, September 5th. Zacks Research raised Docusign from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 9th. Morgan Stanley boosted their price target on Docusign from $86.00 to $90.00 and gave the stock an "equal weight" rating in a report on Monday, September 8th. JMP Securities reaffirmed a "market outperform" rating and set a $124.00 price objective on shares of Docusign in a report on Friday, October 3rd. Finally, Piper Sandler lifted their price objective on shares of Docusign from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fifteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $94.14.

Check Out Our Latest Stock Report on Docusign

Insider Activity

In related news, insider Robert Chatwani sold 13,817 shares of the stock in a transaction dated Wednesday, September 17th. The shares were sold at an average price of $83.10, for a total value of $1,148,192.70. Following the completion of the transaction, the insider owned 71,162 shares of the company's stock, valued at approximately $5,913,562.20. This trade represents a 16.26% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 6,500 shares of the business's stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $71.20, for a total value of $462,800.00. Following the sale, the chief financial officer directly owned 105,660 shares in the company, valued at $7,522,992. The trade was a 5.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 102,533 shares of company stock worth $7,709,933. 1.66% of the stock is owned by insiders.

Docusign Price Performance

NASDAQ DOCU opened at $70.68 on Tuesday. Docusign Inc. has a 1-year low of $66.35 and a 1-year high of $107.86. The business has a 50 day simple moving average of $75.09 and a two-hundred day simple moving average of $77.92. The stock has a market capitalization of $14.21 billion, a PE ratio of 53.14, a P/E/G ratio of 3.38 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million during the quarter, compared to the consensus estimate of $780.35 million. During the same period in the prior year, the company earned $0.97 EPS. The company's quarterly revenue was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, analysts anticipate that Docusign Inc. will post 1.17 EPS for the current fiscal year.

Docusign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

Institutional Ownership by Quarter for Docusign (NASDAQ:DOCU)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Docusign Right Now?

Before you consider Docusign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.

While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.